Steven Corso

Rituximab as First-Line and Maintenance Therapy for Patients With Indolent Non-Hodgkin’s Lymphoma

John D. Hainsworth, Sharlene Litchy, Howard A. Burris et al. · Journal of Clinical Oncology · 2002 · 418 citations

Medicine, Immunology, Pharmacotherapy +13

Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

William Irvin, Christine M. Walko, Karen E. Weck et al. · Journal of Clinical Oncology · 2011 · 179 citations

Medicine, Pharmacokinetics, Pharmacology +17

Phase III Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone: NCCTG N03C5

Charles L. Loprinzi, John W. Kugler, Debra L. Barton et al. · Journal of Clinical Oncology · 2006 · 94 citations

Medicine, Pharmacotherapy, Psychiatry +15

<i>In vivo</i> assessment of the metabolic activity of CYP2D6 diplotypes and alleles

Daniel L. Hertz, Anna C. Snavely, Howard L. McLeod et al. · British Journal of Clinical Pharmacology · 2015 · 57 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity

Daniel L. Hertz, Allison M. Deal, Joseph G. Ibrahim et al. · The Oncologist · 2016 · 54 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +16